MDPI and ACS Style
Fasanaro, E.; Del Bianco, P.; Groff, E.; Riva, A.; Petrangolini, G.; Busato, F.; Stritoni, P.; Scarzello, G.; Loreggian, L.; De Salvo, G.L.
Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM). Cancers 2022, 14, 6192.
https://doi.org/10.3390/cancers14246192
AMA Style
Fasanaro E, Del Bianco P, Groff E, Riva A, Petrangolini G, Busato F, Stritoni P, Scarzello G, Loreggian L, De Salvo GL.
Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM). Cancers. 2022; 14(24):6192.
https://doi.org/10.3390/cancers14246192
Chicago/Turabian Style
Fasanaro, Elena, Paola Del Bianco, Elena Groff, Antonella Riva, Giovanna Petrangolini, Fabio Busato, Paola Stritoni, Giovanni Scarzello, Lucio Loreggian, and Gian Luca De Salvo.
2022. "Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM)" Cancers 14, no. 24: 6192.
https://doi.org/10.3390/cancers14246192
